Trial Profile
Phase I single-dose trial of TT 401 in obese subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2012
Price :
$35
*
At a glance
- Drugs Pegapamodutide (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Jun 2012 Status changed from recruiting to completed.
- 21 Dec 2011 New trial record